Abstract
Medicinal plants are used directly as therapeutic agents in various traditional practices, and medicinal plants like Dioscorea deltoidea, Papaver somniferum, Atropa belladonna, Rauvolfia serpentina, Hyoscyamus niger, Digitalis lanata, Datura metel, Digitalis purpurea, Pilocarpusa bonandi, Cinchona ledgeriana are contributing directly several prescribed medicinals. The ever-increasing trend in the use of medicinal herbs and herbal products in therapeutic purpose, research, and trade has created tremendous pressure on supply from their wild source. Under the circumstances of increasing demand, indiscriminate and over extraction from the wild, habitat destruction, etc., many of the naturally growing medicinal herbs are on the verge of extinction and thus unsustainability in the supply of medicinal plants from natural source. Systematic cultivation of medicinal herbs would be a viable alternative to overcome this unsustainability problem of medicinal plants from the wild source and cultivation offers opportunity to optimize yield and achieve a uniform, high-quality product. Several drugs like cardamom, cannabis, cinnamon, ginger, cinchona, opium, linseed, and fennel are now obtained almost exclusively from cultivation source. Benefits of cultivation of medicinal plants are widely viewed as a means for meeting current and future demands for large volume production of plant-based drugs; cultivation can reduce growing pressures on wild medicinal plants and ensure pure and smooth supply; means of earning livelihood, etc. The WHO has published wide-spectrum guidelines for good agricultural and collection practices for sustainable production of raw material of quality and standardized herbal ingredients to ensure quality of herbal medicines. Medicinal plants may be cultivated by the following: (a) agricultural practice at field level and (b) in vitro production of secondary metabolites. Commercial cultivation at field level (open field, homestead garden, forest floor) is an agronomic practice and offers the opportunity to overcome the problems that are inherent in herbal extracts like misidentification, genetic and phenotypic variability, extract variability and instability, toxic components, and contaminants. The agronomic method of crop cultivation includes systematically the steps like site and season selection, selection of crop, true seed or vegetative propagule, land preparation and basal manuring and fertilization, spacing, seed sowing or seedling transplantation, split application of fertilizer, irrigation, intercultural operation, and weed control and harvesting. Large-scale plant tissue or organ culture for the production of secondary metabolites is an attractive alternative approach to traditional methods of cultivation of drug plants. The advantages of this method are many; it is independent of soil, paste, climatic interference, geographical location, and it can ultimately provide a continuous and reliable source of natural products. Considering the cost involvement, plant tissue culture for secondary metabolites is now limited to only high-value compounds such as diosgenin-derived steroid hormone precursors, digitalis glycosides, berberine isoquinoline alkaloid, taxol, paclitaxel, and several other toxoids—complex diterpene alkaloids. Herbal plants have global market worth about US$62 billion per annum, and so they may be a good export item and wealth of a country and should be cultivated in commercial scale like any other conventional cash crops. As cultivation of medicinal plants at commercial scale is comparatively a new concept in many countries to meet the demand of internal and foreign markets and earning livelihood of the rural people, medicinal plants are important natural wealth and herbal wealth, play significant role in providing primary health-care services to rural people, and serve as raw material in traditional and modern pharmaceutical as well as in cosmetic, agricultural, and food industries. Substantial amount of foreign exchange can be earned by exporting medicinal plants to other countries. In this way, indigenous medicinal plants may play a significant role in the economy of a country.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adeola MO (1992) Importance of wild animals and their parts in the culture, religious festivals, and traditional medicine, of Nigeria. Environ Conserv 19:125–134
Adhikari B (2001) Socio-economic heterogeneity and income distribution: evidence from common property resource management. J Livelihoods 1:22–24
Agrimi LR, Curia C, French D, Mariani-Costantini R (1992) Healing rituals and sacred serpents. Lancet 340:223–225
Alamgir ANM, Ahmed M (2005) Growth and phytochemical investigation of Rauvolfia serpentine Benth. Propagule. Bangladesh J Bot 34(1):7–10
Alamgir ANM, Ahmed M, Mostafa M (1999) A report on distribution of alkaloids and effect of NPK on alkaloid contents of some higher dicotyledons (Metachlamydeae) of Chittagong district. J Natl Bot Soc 53:29–33
Alamgir ANM, Ahmed M, Hossain ME, Islam E (2004) Investigation on the distribution of alkaloids and effect of NPK on the alkaloid content of some dicotyledons (Archichlamydeae). Chittagong Univ J Sci 28(1):103–108
Ali-Shtayeh MS, Yaniv Z, Mahajna J (2000) Ethnobotanical survey in the Palestinian area: a classification of the healing potential of medicinal plants. J Ethnopharmacol 73:221–232
Almeida CFCBR, Albuquerque UP (2002) Uso de plantas e animais medicinais no estado de Pernambuco (Nordeste do Brasil): Um estudo de caso. Interciencia 27:276–284
Al-Quran S (2008) Taxonomical and pharmacological survey of therapeutic plants in Jordan. J Nat Prod 1:10–26
Anonymous (1995) China National Corporation of traditional and herbal medicine. Materia medica commonly used in China. Science Press, Beijing
Anonymous (2006) Japan Kampo medicine manufacturers association. “Annual report of pharmaceutical production in Japan” 2000–2006. http://www.nikkankyo.org/publication/movement.html
Anonymous (2007) Japan speciality agriculture products association. Data of medical crops (crude drugs)
Anonymous (2010) National center for complementary and alternative medicine. Tradit Chin Med. http://nccam.nih.gov/health/whatiscam/chinesemed.htm
Ayensu ES (1996) World medicinal plant resources. In: Chopra VL, Khoshoo TN (eds) Conservation for productive agriculture. ICAR, New Delhi, pp 11–42
Balandrin MJ, Klocke JA (1988) Medicinal, aromatic and industrial materials from plants. In: Bajaj YPJ (ed) Biotechnology in agriculture and forestry. Medicinal and aromatic plant, vol 4. Springer, Berlin, pp 1–36
Banglapedia (2003) National encyclopedia of Bangladesh. In: S Islam (ed) Asiatic society of Bangladesh, vol 4, pp 77–82, 171–177
Bennett EL, Milner-Gulland EJ, Bakarr M, Eves HE, Robinson JG, Wilkie DS (2002) Hunting the world’s wildlife to extinction. Oryx 36:328–329
Borris RP (1996) Natural product research: perspectives from a major pharmaceutical company. J Ethnopharmacol 51:29–38
Cao S, Kingston DGI (2009) Kingston biodiversity conservation and drug discovery: can they be combined? The Suriname and Madagascar experiences. Pharm Biol 47(8):809–823
Bramwell D (2002) How many plant species are there? Plant Talk 28:32–34
Chauhan B, Kumar G, Kalam N, Ansari SH (2013) Current concepts and prospects of herbal nutraceutical: a review. J Adv Pharm Technol Res 4(1):4–8
Costa-Neto EM (2005) Animal-based medicines: biological prospection and the sustainable use of zootherapeutic resources. An Acad Bras Cienc 77:33–43
Crozier A, Clifford MN, Ashihara H (eds) (2007) Plant secondary metabolites: occurrence, structure and role in the human diet. Blackwell Publishing Ltd, Hoboken, pp 1–136
de Silva T (1997) Industrial utilization of medicinal plants in developing countries. In: Bodeker G, Bhat KKS, Burley J, Vantomme P (eds) Medicinal plants for forest conservation and health care. FAO (Non-wood Forest Products 11), Rome, pp 34–44
Dubey NK, Kumar R, Tripathi P (2004) Global promotion of herbal medicine: India’s opportunity. Curr Sci—Bangalore 86:37–41
Duke JA, Ayensu ES (1985) Medicinal plants of China, vol 1 & 2. Reference Publications (Medicinal Plants of the World 4), Algonac
Edwards R (2004) No remedy in sight for herbal ransack. New Sci 181:10–11
FAO (1995) Non-wood forest products for rural income and sustainable development. FAO (Non-wood forest products 7), Rome
Farnsworth NR, Soejarto DD (1991) Global importance of medicinal plants. In: Akerele O, Heywood V, Synge H (eds) The conservation of medicinal plants. Cambridge University Press, Cambridge, pp 25–52
Fowler MW, Scragg AH (1988) Natural products from higher plants and plant cell culture. In: Pais MSS, Mavituna F, Novais JM (eds) Plant cell biotechnology. NATO ASI Series, vol 18. Springer, Berlin, pp 165–177
Gantet P, Memelink J (2002) Transcription factors: tools to engineer the production of pharmacologically active plant metabolites. Trends Pharmacol Sci 23:563–569
Ghani A (2003) Medicinal plants of Bangladesh with chemical constituents and uses, 2nd edn. Asiatic Society of Bangladesh, Ramna
Ghimire SK, McKey D, Aumeeruddy-Thomas Y (2002) Heterogeneity in ethnoecological knowledge and management of medicinal plants in the Himalayas of Nepal: implications for conservation. Ecol Soc 9(6):32–43
Ghorbani A (2005) Studies on pharmaceutical ethnobotany in the region of Turkmen Sahra, north of Iran: (part 1): general results. J Ethnopharmacol 102:58–68
Govaerts R (2001) How many species of seed plants are there? Taxon 50:1085–1090
Groombridge B (ed) (1992) Global biodiversity. Status of the earth’s living resources. Chapman and Hall, London
Grover JK, Yadav S, Vats V (2002) Medicinal plants of India with antidiabetic potential. J Ethnopharmacol 81:81–100
Grünwald J, Büttel K (1996) The European phytotherapeutics market. Drugs Made Ger 39:6–11
Gupta R, Chadha KL (1995) Medicinal and aromatic plants research in India. In: Chadha KL (ed) Advances in horticulture: medicinal and aromatic plants, vol 11. Malhotra Publishing House, New Delhi, pp 1–43
Hamilton A (2006) Plant conservation: an ecosystem approach. Earthscan, London
Hardalova R (1997) The use of medicinal plants in Bulgaria and their protection. In: Newton J (ed) Planta Europaea. Proceedings of the first European conference on the conservation of wild plants. Hyères, France, 2–8 Sept 1995, pp 184–187
He S, Ning S (1997) Utilization and conservation of medicinal plants in China with special reference to Atractylodes lancea. In: Bodeker G, Bhat KKS, Burley J, Vantomme P (eds) Medicinal plants for forest conservation and health care. FAO (Non-wood Forest Products 11), Rome, pp 109–115
Huda MK (2007) An updated enumeration of the family Orchidaceae from Bangladesh. J Orchid Soc India 21(1–2):35–49
IUCN, WHO and WWF (1993) Guidelines on the conservation of medicinal plants. IUCN, WHO and WWF, Gland
Iwu MM (1993) Handbook of African medicinal plants. CRC Press, Boca Raton
Joy PP, Thomas J, Mathew S, Skaria BP (1998) Medicinal plants. Kerala Agricultural University, Aromatic and Medicinal Plants Research Station, Kerala
Kamboj VP (2000) Herbal medicine. Curr Sci—Bangalore 78:35–39
Kang S, Phipps M (2003) A question of attitude: South Korea’s traditional medicine practitioners and wildlife conservation. TRAFFIC East Asia, Hong Kong
Khan B, Abdukadir A, Qureshi R, Mustafa G (2011) Medicinal uses of plants by the inhabitants of Khunjerab National Park, Gilgit, Pakistan. Pak J Bot 43:2301–2310
Kolewe ME, Gaurav V, Roberts SC (2008) Pharmaceutically active natural product synthesis and supply via plant cell culture technology. Mol Pharm 5(2):243–256
Laird SA (1999) The botanical medicine industry. In: ten Kate K, Laird SA (eds) The commercial use of biodiversity. Earthscan, London, pp 78–116
Lambert J, Srivastava J, Vietmeyer N (1997) Medicinal plants. Rescuing a global heritage. World Bank, World Bank technical paper, vol 355. Washington, pp 8–15
Lange D (1996) Untersuchungen zum Heilpflanzenhandel in Deutschland. Ein Beitrag zum internationalen Artenschutz. German Federal Agency for Nature Conservation, Bonn-Bad Godesberg
Lange D (1997) Trade figures for botanical drugs world-wide. Med Plant Conserv 3:16–17
Lange D (1998) Europe’s medicinal and aromatic plants: their use, trade and conservation: an overview. TRAFFIC International, Cambridge
Lange D (1999) Identification training for medicinal and aromatic plants covered by CITES and EU Regulation 2307/97. Lecture script. Version 2-En, 25.5.99. BfNSkripten 11. German Federal Agency for Nature Conservation, Bonn
Lange D (2001) Trade in medicinal and aromatic plants: a financial instrument for nature conservation in Eastern and Southeast Europe? In: Heinze B, Bäurle G, Stolpe G (eds) Financial instruments for nature conservation in Central and Eastern Europe. BfN-Skripten 50. Federal Agency for Nature Conservation, Bonn, pp 157–171
Lange D (2004) Medicinal and aromatic plants: trade, production, and management of botanical resources. In: LE Craker et al. (eds) Proceedings of the XXVI international horticultural congress (IHC)—future for medicinal and aromatic plants. Acta Hort. 629, ISHS, pp 177–197
Lange D, Schippmann U (1999) Checklist of medicinal and aromatic plants and their trade names covered by CITES and EU Regulation 2307/97. Version 3.0. BfNSkripten 8. German Federal Agency for Nature Conservation, Bonn
Lev E (2003) Traditional healing with animals (zootherapy): medieval to present-day Levantine practice. J Ethnopharmacol 86:107–118
Lev E, Amar Z (2002) Ethnopharmacological survey of traditional drugs sold in the Kingdom of Jordan. J Ethnopharmacol 82:131–145
Li TSC, Bedford KE, Sholberg PL (2000) Improved germination of American ginseng seeds under controlled environments. Hort Technol 10:131–135
Mallaa B, Gauchanb DP, Chhetria RB (2015) An ethnobotanical study of medicinal plants used by ethnic people in Parbat district of western Nepal. J Ethnopharmacol 165:103–117
Mantell SH, Smith H (1984) Cultural factors that influence secondary metabolite accumulation in plant cell and tissue cultures. In: Mantell SH, Smith H (eds) Plant biotechnology. Cambridge University Press, Cambridge, pp 75–108
Marshall NT (1998) Searching for a cure: conservation of medicinal wildlife resources in east and southern Africa. TRAFFIC International, Cambridge
Mia MMK (1990) Traditional medicine. In: Ghani A (ed) Traditional medicine. Jahangirnagar University, Savar, p 73
Mian-YingW Brett JW, Jensen CJ, Nowicki D, Chen S, Palu AK, Anderson G (2002) Morinda citrifolia (Noni) A literature review and recent advances in Noni research. Acta Pharmacol Sin 23:1127–1141
Mittermeier RA, Myers N, Thomsen JB, Da Fonseca GAB, Olivier S (1998) Biodiversity hotspots and major tropical wilderness areas: approaches to setting conservation priorities. Conserv Biol 12:516–520
Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TPA (2007) Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 40(3):163–173
Neto EM (2004) Implications and applications of folk zootherapy in the State of Bahia, Northeastern Brazil. Sust Dev 12:161–174
Palevitch D (1991) Agronomy applied to medicinal plant conservation. In: Akerele O, Heywood V, Synge H (eds) Conservation of medicinal plants. Cambridge University Press, Cambridge, pp 167–178
Paturkar M, Khobragade P (2016) Mass cultivation of Sarpagandha (Rauwolfia serpentina Benth. ex Kurz) in consideration with environmental factors and cultivation techniques. Int J Ayurveda Pharma Res 4(10):58–61
Patwardhan B (2005) Traditional medicine: a novel approach for available, accessible and affordable health care, development of traditional medicine in the South-East Asia Region, Korea. World Health Organization
Penso G (1980) WHO inventory of medicinal plants used in different countries. WHO, Geneva
Phillipson JD (1990) Plants as source of valuable products. In: Charlwood BV, Rhodes MJC (eds) Secondary products from plant tissue culture. Clarendon Press, Oxford, pp 1–21
Pierce A, Laird S, Malleson R (2002) Annotated collection of guidelines, standards and regulations for trade in non-timber forest products (NTFPs) and botanicals. Version 1.0. New York, Rainforest Alliance
Poonam AS, Mishra S (2013) Physiological, biochemical and modern biotechnological approach to improvement of Rauwolfia serpentina. J Pharmacy Biol Sci 6(2):73–78
Rao SR, Ravishankar GA (2002) Plant cell cultures: chemical factories of secondary metabolites. Biotechnol Adv 20:101–153
Ravishankar GA, Rao SR (2000) Biotechnological production of phyto-pharmaceuticals. J Biochem Mol Biol Biophys 4:73–102
Rezaei A, Ghanati F, Behmanesh M, Dizaj MM (2011) Ultrasound-potentiated salicylic acid-induced physiological effects and production of Taxol in Hazelnut (Corylus avellana L.) cell culture. Ultrasound Med Biol 37(11):1938–1947
Robinson JG, Bennett EL (2000) Carrying capacity limits to sustainable hunting in tropical forests. In: Robinson JG, Bennett EL (eds) Hunting for sustainability in tropical forests. Columbia University Press, New York, pp 13–30
Rokaya MB, Munzbergovaa Z, Timsina B (2010) Ethnobotanical study of medicinal plants from the Humla district of western Nepal. J Ethnopharmacol 130(2010):485–504
Schippmann U, Leaman DJ, Cunningham AB (2002) Impact of cultivation and gathering of medicinal plants on biodiversity: global trends and issues. In: Biodiversity and the Ecosystem Approach in Agriculture, Forestry and Fisheries. Satellite event on the occasion of the Ninth Regular Session of the Commission on Genetic Resources for Food and Agriculture. FAO, Rome, 12–13 Oct 2002
Seth SD, Sharma B (2004) Medicinal plants of India. Indian J Med Res 120:9–11
Shankar D, Majumdar B (1997) Beyond the biodiversity convention: the challenge facing the biocultural heritage of India’s medicinal plants. In: Bodeker G, Bhat KKS, Burley J, Vantomme P (eds) Medicinal plants for forest conservation and health care. Non-wood forest products 11. FAO, Rome, pp 87–99
Sher H, Hussain F (2009) Ethnobotanical evaluation of some plant resources in Northern part of Pakistan. Afr J Biotechnol 8:4066–4076
Sher H, Aldosari A, Ali A, de Boer HJ (2014) Economic benefits of high value medicinal plants to Pakistani communities: an analysis of current practice and potential. J Ethnobiol Ethnomed 10:71–86
Shetty MR, Harisha GA, Jayanth Y, Kumar A (2014) Production of secondary metabolites from in vitro cultures of Rauwolfia serpentina (L.) Benth. Int J Sci Res Eng Technol 2(12):844–852
Stanbury PF, Whiitaker A, Hall SJ (1999) Principles of fermentation technology, 2nd edn. Butterworth-Heinemann, Oxford
Stockigt J, Obitz P, Flakenhagen H, Lutterbach R, Endress R (1995) Natural products and enzymes from plant cell cultures. Plant Cell Tissue Org Cult 43:914–920
UNESCO (1996) Culture and health, orientation texts world decade for cultural development 1988–1997. Document CLT/DEC/PRO—1996, Paris, France, p 129
Unnikrishnan PM (1998) Animals in ayurveda. Amruth 1(Suppl 1):1–15
Van der Geest S (1997) Is there a Role for traditional medicine in basic health services in Africa? A plea for a community perspective. Trop Med Int Health 2(9):903–911
Vanisree M, Lee CY, Lo SF, Nalawade SM, Lin CY, Tsay HS (2004) Studies on the production of some important secondary metabolites from medicinal plants by plant tissue cultures. Bot Bull Acad Sin 45(1):1–22
Verma S, Singh SP (2008) Current and future status of herbal medicines. Vet World 1:347–350
Verpoorte R (2000) Pharmacognosy in the new millenium: lead finding and biotechnology. J Pharm Pharmacol 52(3):253–262
Vines G (2004) Herbal harvests with a future: towards sustainable sources for medicinal plants. Plant life International. Salisbury, pp 1–10. www.plantlife.org.uk
WHO (2002) General guidelines for methodologies on research and evaluation of traditional medicine. World Health Organization, Geneva
WHO/IUCN/WWF (1993) Guidelines on conservation of medicinal plants. WHO/IUCN/WWF, Gland
Wiart C (2007) Ethnopharmacology of medicinal plants: Asia and Pacific. Humana Press, USA
Wiart C (2012) Ethnopharmacology of medicinal plants: Asia and the Pacific. Humana Press, New York
Wilson EO (1995) Wildlife: legions of the doomed. Time International (South Pacific Edition), pp 77–79
Xiao Pei-gen (1991) The Chinese approach to medicinal plants—their utilization and conservation. In: Akerele O, Heywood V, Synge H (eds) The conservation of medicinal plants. Cambridge University Press, Cambridge, pp 305–313
Yusuf M, Chowdhury JU, Wahab MA, Begum J (2009) Medicinal plants of Bangladesh. Bangladesh Council of Scientific and Industrial Research Laboratories, Chittagong-4220, Bangladesh, p 192
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Alamgir, A.N.M. (2017). Cultivation of Herbal Drugs, Biotechnology, and In Vitro Production of Secondary Metabolites, High-Value Medicinal Plants, Herbal Wealth, and Herbal Trade. In: Therapeutic Use of Medicinal Plants and Their Extracts: Volume 1. Progress in Drug Research, vol 73. Springer, Cham. https://doi.org/10.1007/978-3-319-63862-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-63862-1_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-63861-4
Online ISBN: 978-3-319-63862-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)